Rainmed Medical Ltd (2297) Fair Value & Analysis
Healthcare · HK · Market cap HK$336M
Fair value as of: Aug 13, 2026
From 1 valuation models · updated 3 days ago
Share price −14.8% over the past month.
Below-average quality, and screening another 30% overvalued on our models.
What matters now
- Weak quality (21/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (HK$0.1020 to HK$0.1955) leaves room in how you read the outcome.
Price vs Fair Value (4 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
49‑month range HK$0.1300 – HK$5.28 · fair‑value band HK$0.1020 – HK$0.1955 · the HK$0.1950 price screens above the HK$0.1360 fair value. Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Rainmed Medical Ltd (2297) currently trades at HK$0.1950, while our model-based Fair Value estimate is HK$0.1360, implying the stock looks roughly 30.3% overvalued today. The Quality Score stands at 21/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at HK$19.2M. Revenue declined 32.3% year over year. It earns a return on equity of -20.7%. Net debt stands at HK$10.4M. Fundamentals as of Aug 13, 2026
Our scenario range runs from HK$0.1020 (bear case) to HK$0.1955 (bull case); at HK$0.1950, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 63% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -33% fair-value upside, at -30%, 2297 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when 2297 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 24 · Market factors (momentum, volatility) 19
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instruments related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular …
Full company description
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instruments related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company also offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system; FlashAngio caIMR System, which provides auxiliary diagnosis of coronary artery diseases; and disposable blood pressure transducer, which is used in conjunction with specialized equipment. In addition, it provides reagents and others installation and training services. Rainmed Medical Limited was founded in 2014 and is headquartered in Suzhou, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Rainmed Medical Ltd reported revenue of HK$19.2M in FY2025 versus HK$81.2M in FY2021, a compound −30.3%/yr. Reported net income was −HK$77.1M in FY2025.
2297 screens 30% overvalued. Compare with Abbott Laboratories, →
Peer Group
Medical Devices · 350 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $110.91 | $74.79 | -33% |
| Stryker Corporation SYK | $347.21 | $186.28 | -46% |
| Medtronic plc MDT | $90.76 | $65.57 | -28% |
| Boston Scientific Corporation BSX | $51.42 | $38.44 | -25% |
| Edwards Lifesciences Corporation EW | $93.05 | $41.02 | -56% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥153.60 | ¥147.63 | -4% |
| Shanghai United Imaging Healthcare Co 688271 | ¥110.50 | ¥43.60 | -61% |
| Demant A/S DEMANT | kr 289.60 | kr 161.17 | -44% |
| Getinge AB GETIB | kr 239.30 | kr 192.14 | -20% |
| Sectra AB SECTB | kr 280.00 | kr 66.81 | -76% |
Compare Rainmed Medical Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Rainmed Medical Ltd (2297) overvalued or undervalued?
What is the fair value of 2297?
What is the quality score of 2297?
What is the revenue of Rainmed Medical Ltd (2297)?
What is the net profit margin of 2297?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Rainmed Medical Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.